Novo Nordisk and Anthropic collaborate to advance drug development with Claude

Crypto Insight Summary: Novo Nordisk is turning to Anthropic’s Claude models in a bid to cut the time needed to develop new medicines and bring them to market. The pharmaceutical giant said Wednesday that the partnership will also put frontier AI to the test in the tightly regulated drug-development process. The Danish pharmaceutical company announced the collaboration with... Crypto Insight Analysis: Direction: Neutral Impact: No Impact Horizon: Short-term (1-3 days) Reasoning: AI in pharma is promising but has no immediate crypto implications.